<Anchor>
Germany and Canada restrict AstraZeneca vaccination according to age. However, he pointed out that there is no scientific basis for these measures, saying that the European Medicines Agency has not yet found evidence that it is dangerous for certain age groups.
This news is reporter Park Soo-jin.
<Reporter>
Due to suspected cases of blood clots after vaccination, the German Immunization Commission has suspended AstraZeneca vaccination for the time being, and Canada has also stopped vaccination of AstraZeneca vaccinations for adults under the age of 55.
The European Medicines Agency analyzes that restrictions on the use of vaccines for these specific age groups are not supported.
It says that no specific risk factors for any particular age group have been identified to date.
[Emmer Cook/Director of the European Medicines Agency: Thrombosis symptoms and the causality of the vaccine have not been proven. There is no evidence to limit the use of the AstraZeneca vaccine at any age.]
However, even if it is a rare possibility, a blood clot may occur, and if symptoms develop, we recommend that you seek medical attention immediately.
Pfizer has conducted a clinical trial on 2,200 adolescents aged 12 to 15 in the United States and published a study that showed 100% preventive effect.
Currently, the Pfizer vaccine is only licensed for use in the United States over the age of 16.
Pfizer predicted that the Corona 19 vaccine will be available for children under 16 years of age from this fall through emergency use approval.